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Abstract
BACKGROUND: Activated protein C (APC) has been introduced as a therapeutic agent for treatment
of patients with severe sepsis due to its unique anticoagulant and anti-inflammatory properties in the
vascular system. In this study we investigated novel targets for the anti-inflammatory action of APC in
human macrophages.
METHODS: Using a genome-wide approach, effects of APC on the expression profile in inflammatory
activated human macrophages were analyzed.
RESULTS: We identified, for the first time, genes that are specifically regulated by APC under
inflammatory conditions, such as chromatin binding protein 4B (CHMP4B) and p300/CBP-associated
factor (PCAF), thus indicating a role of APC in the epigenetic control of gene transcription. A functional
assay showed the influence of APC in the acetyltransferase/deacetylase activity of nuclear extracts from
inflamed macrophages.
CONCLUSION: Our data sheds new light on APC targets in inflammation and opens new lines of
investigation that may be explored in order to further elucidate its unique molecule properties.
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Introduction
The process of inflammation in response to injury or infection, a
crucial part of innate immunity, is characterised by activation,
adhesion and transmigration of leukocytes through the vascular
endothelium to the site of inflammation with the aim of locally
repelling microbial invasion and assisting in the repair of damaged
tissues. In inflammation, immunovascular communication of
circulating cells and vascular endothelium is mediated by
production of pro-inflammatory factors such oxidation products,
nitric oxide, inflammatory cytokines and chemokines, and the
expression of adhesion molecules [1]. Although local inflammatory
processes as a defence mechanism are necessarily transient in
nature, requiring a rapid induction and a rapid termination, in
severe infection they have significant potential to spread from the
local site to non-affected tissues and elicit a systemic inflammatory
response. Thus, a severe systemic inflammatory response proceeds
to generalised intravascular inflammation together with shock,
organ dysfunction and high mortality [2].
Monoytes and macrophages are an essential part of innate
immunity. Monocytes can differentiate into dendritic cells and
macrophages and are crucial for the initiation of an adaptive
immune response, clearance of infectious agents as well as
resolution of inflammation. Inflammation due to tissue damage
or infection results in macrophage activation so increasing the
production of cytokines, chemokines and other inflammatory
mediators. The classical activation of macrophages is achieved by
stimulation with interferon-c (INFc) followed by exposure to a
microbial trigger like lipopolysaccharide (LPS) resulting in a pro-
inflammatory phenotype [1,3]. The release of an array of pro-
inflammatory mediators that communicate with cells of the
vasculature plays a key role in the onset of systemic inflammatory
responses. Because of the redundancy of inflammatory mediators
involved, therapeutic intervention in severe systemic inflammatory
response syndrome is challenging. Targeting the major inflamma-
tory cytokines IL-1 or TNF-a, and lipopolysaccharide (LPS) has
thus far been unsuccessful in the treatment of sepsis. Furthermore,
during severe systemic inflammation, disseminated intravascular
coagulation occurs because of the pro-adhesive endothelial
environment and tissue factor expression on monocytes with
consecutive intravascular thrombin formation [3,4].
Activated protein C (APC), a plasma serine protease, is best
known for its ability to control thrombin formation. APC acts as
an anticoagulant by inhibiting activated clotting factors such as
FVa and FVIIIa, thereby attenuating thrombin formation. In
addition to its anticoagulant properties, APC has been shown to
modulate certain cell functions including inflammation, apoptosis,
and vascular permeability [5]. In a previous study, we found that
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APC affected the pro-adhesive endothelial environment by
downregulating the induction of endothelial adhesion molecules
and monocyte chemotactic protein-1 [6]. Recombinant human
APC has been introduced as a therapeutic agent for treatment of
patients with severe sepsis due to its unique anticoagulant and anti-
inflammatory properties [7]. However, the exact mechanism of
the anti-inflammatory action of APC, in particular on inflamma-
tory activated macrophages, is not fully understood. The
anticoagulant effects of APC are due to its binding to endothelial
receptors such as thrombomodulin or EPCR [8]. For the anti-
inflammtory effects, APC interaction with PAR receptors has been
postulated [8,9,10]. However, in our model of inflamed human
monocyte derived macrophages, the PAR-1 pathway seemed not
to be involved in APC mediated changes of cell functions [11].
The precise mechanism of cellular activation by APC hast to be
further elucidated.
Genome-wide approaches provide the ability to survey the
expression level of thousands of genes simultaneously and are
powerful tools for exploring complex interactive networks of genes
and signaling pathways. Because macrophages constitute an
important cellular compartment involved in severe systemic
inflammatory responses and to characterize novel targets for the
anti-inflammatory action of the physiologic anticoagulant APC in
this cellular system, we undertook expanded gene expression
analysis of the whole human transcriptome. Previously, we
described the inflammatory Wnt5A pathway as a novel target
for the anti-inflammatory action of APC as well as for IL-10,
known for it’s anti-inflammatory potential in macrophages [12]. In
our present study we used the same highly standardised setting of
primary human monocyte derived macrophages activated with
LPS and IFNc and whole genome oligonucleotide arrays to define
the complete transcriptome of macrophages in response to
inflammatory activation. Moreover, by anlysing gene expression
data in context of biological functions we defined for the first time
the specific expression profile in response to APC in inflammatory
activated macrophages. Thereby, we identified as targets of APC
signalling, molecules and transcription factors not known to be
expressed in macrophages or assigned to inflammatory responses
so far. The results presented herein describe for the first time a
regulation of chromatin binding protein 4B (CHMP4B), and
p300/CBP-associated factor (PCAF) by APC in inflamed macro-
phages, suggesting a novel role of APC in the epigenetic control of
gene transcription through chromatin remodeling by histone
acteylation/deacetylation.
Material and Methods
Ethics statement
Human monocyte derived macrophages were prepared from
buffy coats of healthy blood donors (blood donation program;
Swiss Red Cross, Zurich, Switzerland). Informed written consent
was obtained from all blood donors at the Zurich Blood Doning
Center (Blutspende Zu¨rich, Ru¨tistrasse 19, 8952 Schlieren,
Switzerland) according to the guidelines of the Ethics Committee
of the Government of Zurich, Kantonale Ethikkommission Zu¨rich
(KEK), Sonneggstrasse 12, CH-8091 Zu¨rich, Switzerland.
Cell culture
Human monocyte derived macrophages were prepared from
buffy coats of healthy blood donors as previously described [12].
Briefly, after separation by Ficoll gradient (Ficoll-paqueTM Plus,
Amersham Biosciences, Amersham Basel, Switzerland) and three
washes with Mg/Ca-free phosphate-buffered saline (PBS, Gibco
Europe, Basel, Switzerland), cells were suspended in Iscove’s
modified Dulbecco’s medium (IMDM; Invitrogen) supplemented
with 10% heat-inactivated pooled human serum (human serum
Off The Clott, PAA, Austria) and seeded at a density of 16107
cells/ml in 6-well tissue culture plates (Falcon Oxnard, USA).
Purified monocytes were obtained after 2 h incubation under cell
culture conditions in a SteriCult tissue culture incubator (Forma
Scientific, Waltham, Massachusetts, USA) and 4 times washing in
prewarmed Geys Balanced Salt solution (Gibco) by adherence
(purity of .98% as determined by Giemsa staining). After 24 h
medium was replaced by IMDM supplemented with 2% human
pooled serum. Cells were stimulated for 8 h with human
recombinant IFN-c (100 U/ml), IL-10 (5 ng/ml, both from
PrepoTech, Rocky Hill, USA), lipopolysaccharide (LPS 10 ng/
mL, from Escherichia coli 055:B5, Difco Laboratories, Detroit,
MI, USA), human recombinant APC, 90 nmol/L (5 ug/mL
XigrisTM, Lilly, Switzerland).
DNA microarray hybridization and analysis
Differential gene expression profiling of human macrophages
was performed by competitive dual color hybridisation on human
whole genome 60-mer oligonucleotide microarrays as described
previously [12]. The complete set of microarray data is deposited
in the ArrayExpress database, accession number E-MEXP-927.
Functional clustering
To analyze the microarray data in the context of biological
functions we used information available from the Gene Ontology
(GO) consortium (http://www.geneontology.org). The GO terms
represent a defined vocabulary describing the biological process,
cellular components, and molecular functions of genes in a
hierarchical acyclic graph structure. Statistical analysis was
performed using GeneGO software. For each of the existing GO
terms, the cumulative number of genes meeting our criteria (e.g.
up- or downregulated) of all genes represented in the microarray
was calculated. The Z score is calculated for every GO term as
described [13]. A positive Z score indicates that there are more
genes meeting the criterion in the specific GO term than expected
by chance. The Z score is transferred to p-values under the
assumption of a hypergeometric distribution.
RNA isolation and quantitative real-time reverse
transcription PCR (RT-PCR)
Total cellular RNA was isolated using the Qiagen RNeasy Mini
Kit (Qiagen, Basel, Switzerland), which included a DNase digest.
Total RNA was quantified spectrophotometrically and equal
amounts (5 mg) were transcribed into cDNA with oligo(d)T
primers and StrataScript RT Reverse Transcriptase using the
StrataScript First-Strand Synthesis System (Stratagene, Rotkreuz,
Switzerland). Duplicates of cDNA were amplified by RT-PCR
with gene-specific primers using the 7500 Fast Real-Time PCR
system (Applied Biosystems Inc., Rotkreuz, Switzerland) and the
Power SYBR Green Master Mix (Applied Biosystems). Sequence-
specific primers were selected using Primer Express v2.0 software
(Applied Biosystems). The following primers were employed for
glyceraldehyde-3-phosphate dehydrogenase (GAPDH): GAPDH
forward, 59-AAC AGC GAC ACC CAC TCC TC-39; GAPDH
reverse, 59-GGA GGG GAG ATT CAG TGT GGT-39. Primers
for cytokines were as follows: IL1b-forward, 59-CAG AAA ACA
TGC CCG T-39, IL1b reverse, 59GCA CTA CCC TAA GGC
AG-39, IL8 forward, 59-AGA CAG CAG AGC ACA CAA GC-3,
IL8 reverse, 59-ATG GTT CCT TCC GGT GGT-39, MCP-1
forward, 59-CCC CAG TCA CCT GCT GTT AT-39, MCP-1
reverse, 59-AGA TCT CCT TGG CCA CAA TG-39, MIP1b
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forward, 59-GAA AAC CTC TTT GCC ACC AA-39, MIP1b
reverse, 59-TCA CTG GGA TCA GCA CAG AC-39, HOXC10
forward, 59-GAC CTG TGG TTC GTG C-39, HOXC10
reverse, 59-GCG GAT GGA TTC GAT CT-39, TIGD4 forward,
59-AGC AAC GAA GAG TGG T-39, TIGD4 reverse, 59-CTC
TGG GGT TAC AGC C-39, PCAF forward, 59-GCA AGT CAA
GGG CTA TGG-39, PCAF reverse, 59-GTG TAC GGG ATC
CGT G-39, CHMP4B forward, 59-ACT TGT ACG GTA CTG
GC-39, CHMP4B reverse, 59-TCG AGA TAT TTA ATA GAC
AGT GC-39, SOCS7 forward, 59-CCG AAA GTT CTA CTA
CTA TGA T-39and SOCS7 reverse, 59-AGA GTA CGG TCA
TGT GC-39. PCR was carried out with an initial denaturation
step (10 min, 95uC) followed by 40 cycles of denaturation (15 sec,
95uC), annealing (30 sec, 55uC), and extension (30 sec, 72uC).
Fluorescence was measured at the end of each extension. Relative
mRNA levels were quantified by RQ Study SDS Software v1.3.1
(Applied Biosystems) using the comparative Ct method. The
expression level of each gene was normalized to GAPDH levels in
each experimental sample. Final data were expressed as mRNA
expression in treated cells relative to expression in untreated cells. A
melting curve analysis was performed for each amplicon to verify the
specificity of each amplification step.
Western blotting
For assaying HOXC10 and SOCS7I protein expression, cells
were lysed with Mammalian Cell Lysis/Extraction reagent
(Sigma-Aldrich Chemical Co., Buchs, Switzerland) supplemented
with complete mini protease inhibitor cocktail tablets (Roche
Diagnostics Schweiz AG, Rotkreuz, Switzerland). After clearing
the lysates by high-speed centrifugation, protein concentrations of
each sample were determined using a Protein Bradford assay (Bio-
Rad Laboratories AG, Reinach, Switzerland). For immunoblot-
ting, 20 mg total protein of each sample was resolved on SDS 4–
15% gradient polyacrylamide gels and transferred to PVDF
membrane (Millipore AG, Zug, Switzerland). After transfer, the
membranes were incubated for 1 hr in blocking solution (5% non-
fat milk in PBS containing 0.1% Tween-20) and then 1 hr with
mouse anti-HOXC10 (1:1000. abnova) or rabbit anti-SOCS7
(1:1000, abcam) in blocking solution. Antibody binding was
detected with a horseradish peroxidase-coupled sheep-anti rabbit
or donkey-anti rabbit secondary antibody diluted 1:10,000
followed by enhanced chemiluminescence (ECL) detection (ECL
Plus, Amersham Pharmacia Biotech, Inc., Uppsala, Sweden).
Measurement of cytokine production
The inflammatory cytokines IL-8, IL-1b, MIP-1b and MCP-1
were measured in undiluted monocyte supernatants using a
multiplex assay on the BioPlex 2200 platform (Bio-Rad, Hercules,
CA, USA), with commercial antibody-coated beads, standards,
and reagents, according to the manufacturer’s instructions
(Bioplex human cytokine multiplex assay system, BioRad).
Complete medium was used as blank. Data were analyzed on
the Bioplex Reader using the BioPlex 3.0 software (Bio-Rad).
Histone acetyltransferase (HAT) activity
HAT activity of nuclear extracts was measured with a
colorimetric assay that measures NADH produced upon acetylation
of a peptide substrate, following manufacturer recommendations
(HATActivity Colorimetric Assay Kit, BioVision, California, USA).
Histone deacetylase (HDAC) activity
HDAC activity of nuclear extracts was measured with a
colorimetric assay, following manufacturer recommendations
(Colorimetric HDAC Activity Assay Kit, BioVision, California,
USA).
Statistical analysis
Data were analyzed with the use of Graphpad-Prism statistical
software (version 4.0). We used an unpaired 2-tailed Student t -test
or, for comparison of data among groups, 1-way ANOVA
followed by the Newman–Keuls test. Probability values ,0.05
were considered statistically significant.
For array data, fold changes (up or down regulated) of gene
expression were calculated using the re-ratio function of Rosetta
Biosoftware that allows direct comparison between two samples
(LPS/INFc and LPS/INFc/APC) that were both hybridized
against a common reference (untreated control). All sequences
regulated by LPS/INFc/APC with a calculated fold change of
more than 2.0 (p,0.01) were subjected to one-way ANOVA
factorial analysis, compared with the significantly regulated
sequences (fold change .2, p value,0.01) by LPS/INFc.
Results
Differential gene expression of inflamed human
macrophages
Human macrophages prepared from buffy coats of healthy
blood donors were cultured for 24 hr and then stimulated with
INF-c and LPS. Unstimulated macrophages were used as the
baseline control. The transcriptional profiles were then deter-
mined by microarray analysis using Agilent human 44k 60-mer
oligonucleotide microarray chips. Profiles of identical experimen-
tal settings from three independent donors were analyzed with
Rosetta biosoftware. After 8hr stimulation, these macrophages
showed more than a 2-fold (p,0.01) change in expression in 2979
genes. Of the 2547 genes affected after 8 hr by INF/LPSc
stimulation, 1692 were up-regulated, (with a maximal change of
222.5-fold) and 1287 were down-regulated (with a maximal
change of 18.0-fold). The maximally regulated genes were ankyrin
repeat domain 22 (ANKRD22, 222-fold increased expression) and
selenoprotein P (SEPP1, 18-fold decreased expression). The
majority of differentially expressed genes were identified as unique
and named in GenBank, whereas the remaining transcripts were
either identified as unnamed expressed sequence tags or were
hypothetical.
To determine which functional categories are over-represented
among regulated genes with a given statistical significance, we
performed automated unbiased clustering using GeneGO soft-
ware. Genes displaying at least 2.0-fold differential expression
levels were classified into various categories based on the biological
function(s) of the encoded protein to determine the global
direction of the molecular response to inflammation (Figure 1).
Classification according to GO biological processes revealed that
most genes up-regulated by LPS/INFc fall into the functional
categories related to immune response and inflammatory response.
In the down-regulated genes, there was an over-representation of
the protein kinase cascade and response to stress functional
categories as well as an under-representation of categories related
to metabolic processes.
Effect of activated protein C on inflamed macrophages
APC has been shown to down-regulate TNF production by
macrophages and to inhibit the production of inflammatory
cytokines and chemokines in LPS-stimulated THP-1 cells [14,15].
To examine the effect of APC in our experimental setup, real-
time PCR was used to verify the mRNA levels of IL-1b and IL-8
as well as MCP-1 and MIP-1b in all samples used for microarray
Action of Activated Protein C in Human Macrophages
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experiments. As shown in Figure 2, APC down-regulates the
mRNA level of IL-1b, IL-8, MCP-1, and MIP-1b (Figure 2A) and
the protein expression of MCP-1, and MIP-1b (Figure 2B) in
macrophages stimulated with LPS/INFc.
In order to define unknown targets of APC on inflamed
macrophages, we compared the mRNA expression profiles of
macrophages incubated with LPS/INFc with or without APC. Re-
ratio analysis using Rosetta Biosoftware followed by one-way
ANOVA [12], revealed 570 genes differentially expressed by
inflammatory activation and these were significantly (more than 2-
fold change, p,0.05) up- or down-regulated by APC. Of the 570
genes affected by APC upon LPS/INFc stimulation, 440 genes
were up-regulated (with a maximal change of 14.8-fold), and 130
genes were down-regulated (with a maximal change of 26.4-fold).
The maximally regulated genes were tigger transposable element
derived 4 (TIGD4, 14.8-fold increased expression) and angiomotin
like 1 (AMOTL1, 26.4-fold decreased expression). A complete list
of the genes specifically regulated by APC is given as supplemental
material (Table S1).
Among the genes down-regulated by APC is Wnt5A, a gene
that recently emerged to be an important factor for the Toll-
mediated inflammatory signaling in macrophages. A detailed
study of the anti-inflammatory impact of Wnt5A regulation by
APC has recently been described [12].
Figure 1. Functional clustering of genes regulated by LPS/INFc. The gene expression profile of macrophages treated with LPS/INFc
compared with untreated control was analyzed with Rosetta Biosoftware [12]. Genes showing at least a 2.0 fold change were selected and
characterized according to their GO biological process in the GeneGO software and compared with the classification of all genes present in the array
in order to find which functional categories were significantly (p,0.05) over- or underrepresented [13] in the genes downregulated (A) or
upregulated (B) by LPS/INFc. The blue bars represent the genes regulated by LPS/INFc and the orange bars represent all genes represented in the
microarray.
doi:10.1371/journal.pone.0015352.g001
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Figure 2. Regulation of inflammatory mediators by APC. (A) Fold induction of IL1b, IL8, MCP1 and MIP1 b mRNA expression in LPS/INFc
stimulated macrophages treated with and without APC for 8 hr. Changes in mRNA expression were normalized to changes in GAPDH expression and
are expressed as mean 6 SD from at least three independent experiments. *p,0.05 (B) Concentrations of IL1b, IL8, MCP1 and MIP1 b secreted by
macrophages. Cells were stimulated with LPS/INFc in the absence or presence of APC. Control cells were untreated. Cytokines were measured in cell
culture supernatants collected 12 hr after treatment using the Bio-Plex Human Cytokine Multiplex Assay on the Bio-Plex 2200 platform. Cytokine
Action of Activated Protein C in Human Macrophages
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To determine which functional clusters were over-represented
among APC regulated genes, we applied the same analysis
(GeneGO software) as in the genes regulated by LPS/INFc
(Figure 3). Among the genes down-regulated by APC, there was
significant under-representation of genes involved in intracellular
transport and protein transport and over-representation of genes
involved in the adenylate inhibiting pathway and the phospholi-
pase C activating pathway. The genes up-regulated by APC
showed an over-representation of genes involved the regulation of
ATPase activity and an under-representation of genes involved in
phosphoinositide metabolic process and negative regulation of
protein amino acid phosphorylation.
Confirmation of microarray results by RT-PCR and
Western Blot
Using quantitative real-time RT-PCR we confirmed the
expression patterns obtained by microarray analysis for selected
genes related to regulation of gene transcription (TIGD4,
HOXC10, CHMP4B and PCAF) and cytokine secretion
(SOCS7). The cytokine IL-10, which has well described anti-
inflammatory properties, was used to compare its effect with the
suspected but not elucidated anti-inflammatory action of APC in
our setting of inflammatory activated macrophages. None of the
selected genes were significantly regulated by IL10 or have been
previously linked to the anti-inflammatory action of APC
(Figure 4).
The regulation was also confirmed at the protein level
(HOXC10 and SOCS7). For the other gene transcripts (TIGD4,
CHMP4B and PCAF) no antibodies were available. APC
significantly up-regulates TIGD4, PCAF and SOCS7 and
HOXC10 and CHMP4B were significantly down-regulated by
APC.
APC alters the balance between acetylase and
deacetylase activity in inflamed macrophages
Transcription of eukaryotic genes is complex and depends on
different co-activators, such as p300, PCAF and c-AMP response
element-binding protein, as well as histone acetyltransferases
(HATs) and histone deacetylases (HDACs). HATs are responsible
mainly for destabilizing the chromatin structure to allow
accessibility to different transcription factors. In contrast, HDACs
serve as co-repressors of gene transcription by restoring the
condensation of DNA in chromatin.
Because PCAF was one of the genes significantly regulated by
APC upon inflammatory stimulus and has acetyltransferase
activity, we hypothesized that APC might regulate activity of
HATs. As shown in Figure 5A, APC significantly downregulates
histone acetyltransferase activity in nuclear extracts of treated
macrophages after 8 hr but not after 45 min exposure. This
indicates that APC has a long-term effect. As gene expression is
regulated by a balance between HAT and HDACs, we also
investigated APC effect on HDACs activity (Figure 5B) and found
that APC inhibits HDAC activity in treated macrophages after
45 min and 8 hr stimulation suggesting a fast and prolonged effect
of APC on HDAC activity.
Discussion
Circulating macrophages play a major role in the immediate
host response to invading microorganisms. The primary functions
of macrophages include the phagocytosis of invading pathogens
and the synthesis and secretion of pro-inflammatory cytokines,
chemokines, and growth factors. In this study, we determined the
transcriptional changes occurring in human macrophages after
inflammatory stimulation (LPS and INFc). The genes mostly
regulated by inflammatory stimuli were ankyrin repeat domain 22
(increased expression) and selenoprotein P (decreased expression).
The ankyrin-repeat domain (ARD) was first discovered as a
repeated sequence in yeast cell-cycle regulation proteins [16,17]. It
is named after ankyrin, a cytoskeletal adapter protein, which
contains 24 tandem copies of the repeat [17]. Since first being
discovered, over 2800 ankyrin repeat proteins have been
identified, each containing between three and 24 copies of the
ankyrin repeat [18,19]. Ankyrin repeats are common in signaling
proteins, and appear to be general protein–protein interaction
motifs [19]. The upregulation of ankyrin repeat domain 22 under
inflammatory conditions is novel and may represent an increase of
several proteins containing this domain that are involved in the
inflammatory response, such as IkB [18]. Selenoprotein P is the
major transporter of selenium, a trace element required for normal
development [20]. The downregulation of selenoprotein P in our
experimental setup is in line with previous findings that human
and/or murine Sepp1 gene promoter activity is impaired by IFN-c,
TNF-a, and IL-1b [21,22] while induced by TGF-b [22] and IL-
10 [23] suggesting a differential regulation of selenoprotein P
expression during inflammatory reactions [18]. Functional clus-
tering of genes significantly regulated by inflammatory stimuli,
showed a significant over-representation of genes involved in the
inflammatory response (upregulated genes) and genes associated
with the lipid metabolic process (downregulated genes). The over-
representation of downregulated genes associated with lipid
metabolic processes highlights the fact that macrophages are an
active source of pro- and anti-inflammatory lipid mediators.
Modulation of genes involved in general cellular metabolic
activities is a prominent feature of macrophage differentiation
and polarization. Also, macrophages are a major component of
adipose tissue and play a role in the metabolic syndrome [24].
We and others have focused on the effects of activated protein C
(APC) on macrophages, cells that play a critical role in initiating,
perpetuating, and modulating the immediate host response to
invading microorganisms. Activated protein C has been shown to
exert direct anti-inflammatory effects on macrophages by
inhibiting the production of pro-inflammatory cytokines [25,26].
Using a genome wide approach we tried to identify novel targets
for the anti-inflammatory action of APC. The genes most highly
regulated by APC were TIGD4 (increased) and angiomotin like 1
(decreased). TIGD4 belongs to the tigger subfamily of the pogo
superfamily of DNA-mediated transposons in humans [27]. These
proteins are related to DNA transposons found in fungi and
nematodes. They are also very similar to the major mammalian
centromere protein B [27]. Other novel APC targets were
chromatin binding protein 4B (CHMP4B), and p300/CBP-
associated factor (PCAF), which may indicate a role of APC in
the epigenetic control of gene transcription. It is known that PCAF
has histone acetyltransferase activity, and through an acetyltrans-
ferase activity assay we were able to show that APC inhibits
histone acetyltransferase activity in nuclear extracts from inflamed
macrophages (Figure 5A). In health, the expression of genes
coding for many pro-inflammatory cytokines remains silent.
Mechanisms of transcriptional repression dominate until over-
concentrations in treated cells were normalized to the concentrations in control cells and are presented as mean 6 SEM from three independent
experiments. *p,0.05.
doi:10.1371/journal.pone.0015352.g002
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come by stimulation from extracellular stress signals such as
microbial products via the Toll like receptors. Although several
transcription factors initiate de novo expression of pro-inflammatory
cytokines, synthesis and secretion are tightly controlled events.
Therefore, any mechanism for cytokine production is a potential
target for acetylation and histone acetyltransferase (HAT) and
deacetylase (HDAC) activity regulation. Acetylation of transcrip-
tion factors can alter interactions between transcription factors and
DNA and among different transcription factors, and is an integral
part of the transcription and differentiation processes. HATs are
responsible mainly for destabilizing the chromatin structure to
allow accessibility of different transcription factors, including NF-
Figure 3. Functional clustering of genes regulated by APC in inflamed macrophages. The gene expression profile of macrophages treated
with LPS/INFc vs LPS/INFc/APC was analyzed with Rosetta Biosoftware. Genes showing at least a 2.0 fold change were selected and characterized
according to their GO biological process in the GeneGO software and compared with the classification of all genes present in the array in order to find
which functional categories were significantly (p,0.05) over or under-represented in the genes downregulated (A) or upregulated (B) by APC. The
blue bars represent the genes regulated by LPS/INFc and the orange bars represent all genes present in the array.
doi:10.1371/journal.pone.0015352.g003
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kB to the transcriptional site in the DNA. NF-kB can induce
histone acetylation and other histone modifications in a temporal
manner [28] leading to recruitment of other co-activator and re-
modeling complexes and the induction of inflammatory gene
expression [29]. A recent study showed that HAT activity would
be required to ensure the time-dependent induction of the
inflammatory genes IL6, IL8 [30,31], therefore an inhibition of
HAT activity would contribute to the downregulation of these pro-
inflammatory cytokines.
The inhibition of HDAC activity by APC was unexpected, but
several experimental studies have demonstrated that HDAC
inhibitors can modulate immune responses [32,33,34]. Recent
studies have shown that pre-treatment with suberoylanilide
hydroxamic acid (SAHA), an HDAC inhibitor, significantly
reduced LPS-induced secretion of TNF-a by peritoneal macro-
phages [32] by impairing transcription factor recruitment [35].
Our results suggest that APC exerts its anti-inflammatory action
by altering the acetylation balance in inflamed macrophages.
Among the genes regulated by APC was also the homeobox
domain C10 (HOXC10). HOXC10 is one of the highly conserved
HOXC family members of transcription factors that play an
important role in morphogenesis, cell differentiation, and
proliferation [36,37,38]. The HOXC protein levels are controlled
during cell differentiation and proliferation. Selected Hox proteins
have been shown to directly and indirectly regulate the expression
of many angiogenic and growth factors, including basic fibroblast
growth factor, vascular endothelial growth factor, IL8, and Ang2
[38]. The functional role of HOXC10 in inflammation is a
question that needs to be clarified in further studies.
SOCS (suppressor of cytokine signaling) proteins are known to
act as negative regulators of cytokine action via inhibition of JAK/
STAT signaling [39]. The SOCS family consists of 8 proteins
(cytokine-inducible SH2-containing protein [CIS] and SOCS1-
SOCS7). There is very little known about the function of SOCS7.
It has been shown to interact with vinexin [40]. As vinexin is
involved in the signal transduction from EGF-R to JNK and in
cytoskeletal organization and cell spreading, SOCS7 could
modulate these functions and thus play a role in adhesion-
dependent signaling and in cytoskeletal remodeling in normal and
transformed cells [41]. The observation that SOCS7 expression is
induced by APC is novel and precise consequences resulting from
this induction should be further elucidated.
Figure 4. Statistical analysis of genes exclusively affected by APC in inflamed macrophages. In a first step of data analysis, fold changes
(up or down regulated) of gene expression were calculated using the re-ratio function of Rosetta Biosoftware that allows direct comparison between
two samples (LPS/INFc and LPS/INFc/APC) that were both hybridized against a common reference (untreated control). All sequences with a
calculated fold change of more than 2.0 (p,0.01) were subjected to one-way ANOVA factorial analysis, compared with the significantly regulated
sequences (fold change .2, p value,0.01) by LPS/INFc. The ANOVA plot displays each gene (dot) in relation to its p-value (y axis) and the ranked
sequence number (x-axis). Effects are considered significant at a p-value ,0.01. Significantly regulated genes are plotted below the dashed red line.
Highlighted genes, represented in red, were confirmed by real-time PCR (bar graphs) and when possible (antibody availability) by Western Blot.
doi:10.1371/journal.pone.0015352.g004
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